The Trump administration has promised to delay sector-specific tariffs for both firms, and more drugmakers could join the ...

President Donald Trump and the CEO of Pfizer announce a new drug pricing deal to lower drug costs for Americans.

Pfizer said it would pay as much as $7.3 billion for Metsera as it looks to profit from soaring demand for weight-loss treatments.

Not just any pharmaceutical stock will do, though. They aren't all created equal. Let's discuss two leaders in the industry ...